Cancer Research | American Association for Cancer Research

Skip Nav Destination

Current Issue

Volume 82,

Issue 22

15 November 2022

About the Journal

Cancer Research publishes original studies, reviews, and opinion pieces offering significance and broad impact to a diverse audience. Cancer Research seeks manuscripts that offer pathobiological and translational impact to inform the personal, clinical, and societal problems posed by cancer. Read More About the Journal

Editor-in-Chief

Chi Van Dang

View Full Editorial Board

Impact Factor

13.312

SUBMIT TO JOURNAL

Featured Articles

An Exercise-Induced Metabolic Shield in Distant Organs Blocks Cancer Progression and Metastatic Dissemination

Danna Sheinboim, et al.

Clonal Hematopoiesis of Indeterminate Potential in Patients with Solid Tumor Malignancies

Catherine H. Marshall, et al.

Global DNA Methylation Analysis of Cancer-Associated Fibroblasts Reveals Extensive Epigenetic Rewiring Linked with RUNX1 Upregulation in Breast Cancer Stroma

Coral Halperin, et al.

Trending - Altmetric

An Exercise-Induced Metabolic Shield in Distant Organs Blocks Cancer Progression and Metastatic Dissemination

Last mentioned on Friday November 25 2022

Targeting RNA Polymerase I with an Oral Small Molecule CX-5461 Inhibits Ribosomal RNA Synthesis and Solid Tumor Growth

Last mentioned on Thursday November 24 2022

MYC- and MIZ1-Dependent Vesicular Transport of Double-Strand RNA Controls Immune Evasion in Pancreatic Ductal Adenocarcinoma

Last mentioned on Thursday November 24 2022

Abstract 2320: Ivermectin suppresses pancreatic cancer via mitochondria dysfunction

Last mentioned on Thursday November 24 2022

Abstract P5-18-11: Impact of supportive therapies on tolerance of aromatase inhibitors in patients with early-stage, hormone-positive breast cancer

Last mentioned on Thursday November 24 2022

Latest
Most Read
Most Cited

Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling

Aberrant L-Fucose accumulation and increased core fucosylation are metabolic liabilities in mesenchymal glioblastoma

Loss of NF1 in melanoma confers sensitivity to SYK kinase inhibition

The oncogenic FOXL2 C134W mutation is a key driver of granulosa cell tumors

Tweets by CR_AACR

About the Journal

Editor-in-Chief

Impact Factor

Featured Articles

An Exercise-Induced Metabolic Shield in Distant Organs Blocks Cancer Progression and Metastatic Dissemination

Clonal Hematopoiesis of Indeterminate Potential in Patients with Solid Tumor Malignancies

Global DNA Methylation Analysis of Cancer-Associated Fibroblasts Reveals Extensive Epigenetic Rewiring Linked with RUNX1 Upregulation in Breast Cancer Stroma

Trending - Altmetric

AACR Journals

This Feature Is Available To Subscribers Only